Clinical Trial Update: A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

View source ↗

Summary

This clinical trial update reports long-term follow-up results for patients who completed the PEP005-016 or PEP005-025 studies in actinic keratosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratosis

Drugs mentioned

• PEP005 (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Actinic Keratosis | Status: COMPLETED